pancreatic polypeptide
Showing 1 - 25 of 4,106
Pancreatic Tumor, Benign, Pancreatic Tumors, Pancreatic Adenocarcinoma Trial in Houston (Distal Pancreatectomy Sealing Using
Completed
- Pancreatic Tumor, Benign
- +13 more
- Distal Pancreatectomy Sealing Using LTW
-
Houston, TexasBaylor CHI St. Luke's Medical Center
Apr 4, 2022
Eating Disorder, Bulimia Nervosa Trial (Acipimox, Placebo)
Enrolling by invitation
- Eating Disorder
- Bulimia Nervosa
- Acipimox
- Placebo
- (no location specified)
Jul 19, 2022
Type1diabetes Trial in Paris (12 ml total blood tubes volume, Fecal sample)
Completed
- Type1diabetes
- 12 ml total blood tubes volume
- Fecal sample
-
Paris, FranceCochin Hospital
Apr 16, 2021
Obesity Trial in London (PP1420, Placebo)
Terminated
- Obesity
- PP1420
- Placebo
-
London, United KingdomNIHR/ Wellcome Trust Imperial Clinical Research Facility
Sep 21, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)
Completed
- Gastrinoma
- +8 more
- Capecitabine
- +2 more
-
Stanford, CaliforniaStanford University Medical Center
Apr 8, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)
Completed
- Gastrinoma
- +8 more
- regorafenib
- laboratory biomarker analysis
-
Scottsdale, Arizona
- +4 more
Nov 15, 2021
Obesity Trial in London (PP 1420, Placebo)
Completed
- Obesity
- PP 1420
- Placebo
-
London, United KingdomSir John McMichael Centre for Clinical Studies, Imperial College
Jan 25, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in Boston (everolimus, )
Obesity, Diabetes, Type 2, Metabolic Syndrome Trial (Cola beverage with aspartame and acesulfame K, Cola beverage with sucrose
Completed
- Obesity
- +2 more
- Cola beverage with aspartame and acesulfame K
- Cola beverage with sucrose and stevia
- (no location specified)
Dec 8, 2022
Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in
Completed
- Gastrin-Producing Neuroendocrine Tumor
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 25, 2020
Hunger Trial in Leuven (3 pmol/kg*min pancreatic polypeptide, 10 pmol/kg*min pancreatic polypeptide, Placebo)
Completed
- Hunger
- 3 pmol/kg*min pancreatic polypeptide
- +2 more
-
Leuven, BelgiumJan Tack
Feb 22, 2019
Prader-Willi Syndrome, Hyperphagia Trial in Bronx (Intranasal Oxytocin (IN-OXT), Matched Placebo)
Recruiting
- Prader-Willi Syndrome
- Hyperphagia
- Intranasal Oxytocin (IN-OXT)
- Matched Placebo
-
Bronx, New YorkMontefiore Medical Center, Albert Einstein College of Medicine
Feb 16, 2022
Overweight and Obesity, Healthy Diet Trial in Pamplona (Standard serving utensil toolkit, Optimsed portion-control toolkit)
Recruiting
- Overweight and Obesity
- Healthy Diet
- Standard serving utensil toolkit
- Optimsed portion-control toolkit
-
Pamplona, Navarra, SpainUniversity of Navarra, Dept. of Food Science and Physiology, Cen
Nov 21, 2022
Healthy Trial in Copenhagen, Hvidovre (Proton Pump inhibitor, Placebo)
Recruiting
- Healthy
- Proton Pump inhibitor
- Placebo
-
Copenhagen, Capital, Denmark
- +1 more
Nov 1, 2023
Food Preferences, Eating Behavior, Psychological Trial in Herlev (Picture exposure)
Recruiting
- Food Preferences
- +2 more
- Picture exposure
-
Herlev, DenmarkSteno Diabetes Center Copenhagen
Jan 31, 2023
Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome Trial in New York (Metformin, Placebo)
Active, not recruiting
- Polycystic Ovary Syndrome
- +2 more
- Metformin
- Placebo
-
New York, New YorkColumbia University Medical Center
Jul 19, 2022
PreDiabetes Trial (Beef, Poultry)
Not yet recruiting
- PreDiabetes
- Beef
- Poultry
- (no location specified)
Jul 12, 2022
Obesity Trial in Nashville (Oral Glucose Tolerance Test (OGTT), Human Ghrelin, Saline)
Active, not recruiting
- Obesity
- Oral Glucose Tolerance Test (OGTT)
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Nov 18, 2022
Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)
Completed
- Neuroendocrine Tumor
- Lutetium-177 DOTATATE
-
Houston, TexasExcel Diagnostics & Nuclear Oncology Center
Apr 16, 2023
Type 2 Diabetes (T2DM) Trial (Endovascular Denervation System (Netrod))
Not yet recruiting
- Type 2 Diabetes Mellitus (T2DM)
- Endovascular Denervation System (Netrod)
- (no location specified)
Jan 5, 2023
Gastroparesis With Diabetes Trial in Hvidovre (G-POEM, Sham)
Recruiting
- Gastroparesis With Diabetes Mellitus
- G-POEM
- Sham
-
Hvidovre, Region Hovedstaden, DenmarkMelina Svraka Hansen
Apr 25, 2023
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
Recruiting
- Acute Pancreatitis
-
Los Angeles, California
- +12 more
May 13, 2022
Ulcerative Colitis Trial in Xi'an (G132 system, Beijing PINS Medical Co., China)
Not yet recruiting
- Ulcerative Colitis
- G132 system, Beijing PINS Medical Co., China
-
Xi'an, Shaanxi, ChinaXijing Hospital
Jun 8, 2023
Pancreatic Cancer, Pancreatic Carcinoma Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)
Completed
- Pancreatic Cancer
- Pancreatic Carcinoma
- iNeo-Vac-P01
- GM-CSF
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Nov 15, 2021
Amino Acid Trial in Bobigny (Whey Protein Isolate 894 Fonterra, Zein Sigma-Aldrich W555025, Protein-free test-meal)
Completed
- Amino Acid
- Whey Protein Isolate 894 Fonterra
- +2 more
-
Bobigny, FranceCRNH Ile de France
May 31, 2022